Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

What is the optimum prophylaxis against gastrointestinal haemorrhage for patients undergoing adult cardiac surgery: histamine receptor antagonists, or proton-pump inhibitors?

Patel AJ, Som R.

Interact Cardiovasc Thorac Surg. 2013 Mar;16(3):356-60. doi: 10.1093/icvts/ivs483. Epub 2012 Dec 2. Review.

2.

Is routine stress ulcer prophylaxis of benefit for patients undergoing cardiac surgery?

Shin JS, Abah U.

Interact Cardiovasc Thorac Surg. 2012 May;14(5):622-8. doi: 10.1093/icvts/ivs019. Epub 2012 Feb 17. Review.

3.

Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.

Alhazzani W, Alenezi F, Jaeschke RZ, Moayyedi P, Cook DJ.

Crit Care Med. 2013 Mar;41(3):693-705. doi: 10.1097/CCM.0b013e3182758734. Review.

PMID:
23318494
4.

The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.

Lin PC, Chang CH, Hsu PI, Tseng PL, Huang YB.

Crit Care Med. 2010 Apr;38(4):1197-205. doi: 10.1097/CCM.0b013e3181d69ccf.

PMID:
20173630
5.

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.

6.

Proton pump inhibitors therapy vs H2 receptor antagonists therapy for upper gastrointestinal bleeding after endoscopy: A meta-analysis.

Zhang YS, Li Q, He BS, Liu R, Li ZJ.

World J Gastroenterol. 2015 May 28;21(20):6341-51. doi: 10.3748/wjg.v21.i20.6341. Review.

7.

Gastric Acid Suppressant Prophylaxis in Pediatric Intensive Care: Current Practice as Reflected in a Large Administrative Database.

Costarino AT, Dai D, Feng R, Feudtner C, Guevara JP.

Pediatr Crit Care Med. 2015 Sep;16(7):605-12. doi: 10.1097/PCC.0000000000000427.

PMID:
25901549
8.

Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study.

Bateman BT, Bykov K, Choudhry NK, Schneeweiss S, Gagne JJ, Polinski JM, Franklin JM, Doherty M, Fischer MA, Rassen JA.

BMJ. 2013 Sep 19;347:f5416. doi: 10.1136/bmj.f5416.

9.

Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.

MacLaren R, Reynolds PM, Allen RR.

JAMA Intern Med. 2014 Apr;174(4):564-74. doi: 10.1001/jamainternmed.2013.14673.

PMID:
24535015
10.

Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials.

Alshamsi F, Belley-Cote E, Cook D, Almenawer SA, Alqahtani Z, Perri D, Thabane L, Al-Omari A, Lewis K, Guyatt G, Alhazzani W.

Crit Care. 2016 May 4;20(1):120. doi: 10.1186/s13054-016-1305-6. Review.

12.

Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.

Kantorova I, Svoboda P, Scheer P, Doubek J, Rehorkova D, Bosakova H, Ochmann J.

Hepatogastroenterology. 2004 May-Jun;51(57):757-61.

PMID:
15143910
13.

Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis.

Barkun AN, Bardou M, Pham CQ, Martel M.

Am J Gastroenterol. 2012 Apr;107(4):507-20; quiz 521. doi: 10.1038/ajg.2011.474. Epub 2012 Jan 31.

PMID:
22290403
15.

Proton pump inhibitors are associated with lower gastrointestinal tract bleeding in low-dose aspirin users with ischaemic heart disease.

Miyake K, Akimoto T, Hanada Y, Nagoya H, Kodaka Y, Ueki N, Kusunoki M, Kawagoe T, Futagami S, Takahashi Y, Takano H, Sakamoto C.

Dig Liver Dis. 2015 Sep;47(9):757-62. doi: 10.1016/j.dld.2015.05.020. Epub 2015 Jun 2.

PMID:
26105589
16.

Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea.

Buendgens L, Bruensing J, Matthes M, Dückers H, Luedde T, Trautwein C, Tacke F, Koch A.

J Crit Care. 2014 Aug;29(4):696.e11-5. doi: 10.1016/j.jcrc.2014.03.002. Epub 2014 Mar 7.

PMID:
24674763
17.

Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.

MacLaren R, Campbell J.

Crit Care Med. 2014 Apr;42(4):809-15. doi: 10.1097/CCM.0000000000000032.

PMID:
24365863
18.

Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.

Tofil NM, Benner KW, Fuller MP, Winkler MK.

J Crit Care. 2008 Sep;23(3):416-21. doi: 10.1016/j.jcrc.2007.10.038.

PMID:
18725049
19.

Effect of Helicobacter pylori eradication therapy on risk of hospitalization for a major ulcer event.

Hsiao FY, Tsai YW, Wen YW, Kuo KN, Tsai CR, Huang WF.

Pharmacotherapy. 2011 Mar;31(3):239-47. doi: 10.1592/phco.31.3.239.

PMID:
21361733
20.

Stress-related mucosal bleeding in critically ill oncology patients.

Bruno JJ, Canada TW, Wakefield CD, Nates JL.

J Oncol Pharm Pract. 2009 Mar;15(1):9-16. doi: 10.1177/1078155208094122. Epub 2008 Aug 27.

PMID:
18753185

Supplemental Content

Support Center